Previous Close | 219.20 |
Open | 218.10 |
Bid | 217.10 x N/A |
Ask | 218.60 x N/A |
Day's Range | 216.60 - 218.70 |
52 Week Range | 159.80 - 238.00 |
Volume | |
Avg. Volume | 777 |
Market Cap | 39.424B |
Beta (5Y Monthly) | 1.52 |
PE Ratio (TTM) | 31.85 |
EPS (TTM) | 6.80 |
Earnings Date | May 02, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 279.06 |
IQVIA Holdings' (IQV) first-quarter 2024 revenues are likely to have benefited from growth in the Technology and Analytics, and Research and Development segments.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for IQVIA (IQV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]